
The UK Government has announced plans to launch a pilot programme which will provide GPs with Novo Nordisk’s Wegovy (semaglutide), …

AstraZeneca has announced that its post-marketing phase 4 ANNEXA-I trial has been stopped early after reaching its pre-specified stopping criteria. …

French pharmaceutical and healthcare company Sanofi have announced positive trial data from its phase 2 clinical study into its relapsing …

Danish CRISPR-based microbial gene therapy company SNIPR Biome have announced positive interim data from its phase 1 clinical trial with …

US clinical stage biotherapeutics company Bellerophon Therapeutics has announced that the last patient has completed its phase 3 REBUILD study, …

CureVac and GSK have announced that the first patient in the phase 1 section of their combined phase 1/2 trial …

Eli Lilly has announced positive results from the TRAILBLAZER-ALZ 2 phase 3 trial assessing donanemab’s ability to slow cognitive and …

The UK government has announced that thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial, …

TILT Biotherapeutics today announced a clinical trial collaboration agreement with MSD, to evaluate TILT’s adenoviral cancer immunotherapy, TILT-123, in combination …

Biopharma firm AI Therapeutics is partnering with Yale School of Medicine to launch a new clinical trial to identify the efficacy …

A UK wide trial called MND-SMART has invited hundreds of people with motor neurone disease (MND) to participate. It will …

Rhythm Pharma’s obesity drug setmelanotide achieved positive results in two pivotal Phase 3 trials. In both studies, setmelanotide met its …

A trial of the drug sildenafil, commonly sold under the brand name Viagra, has been halted immediately after the death …

Takeda announced that it had completed the enrolment for the largest clinical trial in its history, having enrolled 20,100 children …

AstraZeneca’s clinical trial for head and neck cancer had previously been put on partial hold by the FDA due to …